Revealing the macromolecular targets of complex natural products

Nature Chemistry

Volumn 6, Issue 12, 2014, Pages 1072-1078

  Reker, Daniel ^a   Perna, Anna M ^a   Rodrigues, Tiago ^a   Schneider, Petra ^a   Reutlinger, Michael ^a   Mönch, Bettina ^b   Koeberle, Andreas ^b   Lamers, Christina ^c   Gabler, Matthias ^c   Steinmetz, Heinrich ^d   Müller, Rolf ^d   Schubert Zsilavecz, Manfred ^c   Werz, Oliver ^b   Schneider, Gisbert ^a  

^a ETH ZURICH   (Switzerland)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c GOETHE UNIVERSITY   (Germany)

^d SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; ARCHAZOLID A; BIOLOGICAL PRODUCT; CELL RECEPTOR; FARNESOID X-ACTIVATED RECEPTOR; MACROLIDE; MACROMOLECULE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; THIAZOLE DERIVATIVE;

ANTAGONISTS AND INHIBITORS; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DESIGN; DRUG DEVELOPMENT; MACROMOLECULE; PHYSIOLOGY; PROCEDURES;

ARACHIDONIC ACID; BIOLOGICAL PRODUCTS; DRUG DESIGN; DRUG DISCOVERY; MACROLIDES; MACROMOLECULAR SUBSTANCES; MOLECULAR STRUCTURE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; THIAZOLES; VACUOLAR PROTON-TRANSLOCATING ATPASES;

EID: 84911496459     PISSN: 17554330     EISSN: 17554349     Source Type: Journal    
DOI: 10.1038/nchem.2095     Document Type: Article

References (48)

1. Koehn, F. E. & Carter, G. T. The evolving role of natural products in drug discovery. Nature Rev. Drug Discov. 4, 206-220 (2005
2. Harvey, A. L. Natural products in drug discovery. Drug Discov. Today 13, 894-901 (2008
3. Wetzel, S. et al. Interactive exploration of chemical space with Scaffold Hunter. Nature Chem. Biol. 5, 581-583 (2009
4. Larsson, J., Gottfries, J., Muresan, S. & Backlund, A. ChemGPS-NP: tuned for navigation in biologically relevant chemical space. J. Nat. Prod. 70, 789-794 (2007
5. Rosén, J., Gottfries, J., Muresan, S., Backlund, A. & Oprea, T. I. Novel chemical space exploration via natural products. J. Med. Chem. 52, 1953-1962 (2009
6. Bon, R. S. & Waldmann, H. Bioactivity-guided navigation of chemical space. Acc. Chem. Res. 43, 1103-1114 (2010
7. Renner, S. et al. Bioactivity-guided mapping and navigation of chemical space. Nature Chem. Biol. 5, 585-592 (2009
8. Huigens, R. W. III et al. A ring-distortion strategy to construct stereochemically complex and structurally diverse compounds from natural products. Nature Chem. 5, 195-202 (2013
9. Lachance, H., Wetzel, S., Kumar, K. & Waldmann, H. Charting, navigating, and populating natural product chemical space for drug discovery. J. Med. Chem. 55, 5989-6001 (2012
10. Rollinger, J. M., Stuppner, H., & Langer, T. in Natural Compounds as Drugs Vol. 1 (eds Petersen, F. & Amstutz, R.) 211-249 (Birkhäuser, 2008
11. Hopkins, A. L. Drug discovery: predicting promiscuity. Nature 462, 167-168 (2009
12. Rollinger, J. M. Accessing target information by virtual parallel screening-the impact on natural product research. Phytochem. Lett. 2, 53-58 (2009
13. Lagunin, A., Filimonov, D. & Poroikov, V. Multi-targeted natural products evaluation based on biological activity prediction with PASS. Curr. Pharm. Des. 16, 1703-1717 (2010
14. Over, B. et al. Natural-product-derived fragments for fragment-based ligand discovery. Nature Chem. 5, 21-28 (2013
15. Schmid, F., Jessen, H. J., Burcha, P. & Gademann, K. Truncated militarinone fragments identified by total chemical synthesis induce neurite outgrowth. Med. Chem. Commun. 4, 135-139 (2013
16. Schneider, P. & Schneider, G. Collection of bioactive reference compounds for focused library design. QSAR Comb. Sci. 22, 713-718 (2003
17. Schneider, G., Neidhart, W., Giller, T. & Schmid, G. ?Scaffold-hopping' by topological pharmacophore search: a contribution to virtual screening. Angew. Chem. Int. Ed. 38, 2894-2896 (1999
18. Reutlinger, M. et al. Chemically advanced template search (CATS) for scaffoldhopping and prospective target prediction for ?orphan' molecules. Mol. Inf. 32, 133-138 (2013
19. Schneider, P., Tanrikulu, Y. & Schneider G. Self-organizing maps in drug discovery: compound library design, scaffold-hopping, repurposing. Curr. Med. Chem. 16, 258-266 (2009
20. Grabowski, K., Baringhaus, K. H. & Schneider, G. Scaffold diversity of natural products: inspiration for combinatorial library design. Nat. Prod. Rep. 25, 892-904 (2008
21. CRC Chemical Database Dictionary of Natural Products. Available at http://dnp. chemnetbase.com/
22. Lee, M-L. & Schneider, G. Scaffold architecture and pharmacophoric properties of natural products and trade drugs: application in the design of natural product-based combinatorial libraries. J. Comb. Chem. 3, 284-289 (2001
23. Reker, D., Rodrigues, T., Schneider, P. & Schneider, G. Identifying the macromolecular targets of de novo designed chemical entities through self-organizing map consensus. Proc. Natl Acad. Sci. USA 111, 4067-4072 (2014
24. Faller, B., Ottaviani, G., Ertl, P., Berellini, G. & Collis, A. Evolution of the physicochemical properties of marketed drugs: can history foretell the future? Drug Discov. Today 16, 976-984 (2011
25. López-Vallejo, F., Giulianotti, M. A., Houghten, R. A. & Medina-Franco, J. L. Expanding the medicinally relevant chemical space with compound libraries. Drug Discov. Today 17, 718-726 (2012
26. Lewell, X. Q., Judd, D. B., Watson, S. P. & Hann, M. M. RECAP-retrosynthetic combinatorial analysis procedure: a powerful new technique for identifying privileged molecular fragments with useful applications in combinatorial chemistry. J. Chem. Inf. Comput. Sci. 38, 511-522 (1998
27. Huss, M. & Wieczorek, H. Inhibitors of V-ATPases: old and new players. J. Exp. Biol. 212, 341-346 (2009
28. von Schwarzenberg, K. et al. Mode of cell death induction by pharmacological vacuolar H+-ATPase (V-ATPase) inhibition. J. Biol. Chem. 288, 1385-1396 (2013
29. Wiedmann, R. M. et al. The V-ATPase-inhibitor archazolid abrogates tumor metastasis via inhibition of endocytic activation of the Rho-GTPase Rac1. Cancer Res. 72, 5976-5987 (2012
30. Huss, M. et al. Archazolid and apicularen: novel specific V-ATPase inhibitors. BMC Biochem. 6, 13 (2005
31. Horstmann, N. et al. Archazolid A-15-O-?-D-glucopyranoside and iso-archazolid B: Potent V-ATPase inhibitory polyketides from the myxobacteria Cystobacter violaceus and Archangium gephyra. J. Nat. Prod. 74, 1100-1105 (2011
32. Dreisigacker, S. et al. Understanding the inhibitory effect of highly potent and selective archazolides binding to the vacuolar ATPase. J. Chem. Inf. Model. 52, 2265-2272 (2012
33. Rizzo, T. R., Pudlo, N., Farrell, L. & Leaver, A. Specificity of arachidonic acid-induced inhibition of growth and activation of c-jun kinases and p38 mitogen-activated protein kinase in hematopoietic cells. Prostag. Leukotr. Ess. 66, 31-40 (2002
34. Viscardi, R. M. & Max, S. R. Unsaturated fatty acid modulation of glucocorticoid receptor binding in L2 cells. Steroids 58, 357-361 (1993
35. Vecchio, A. J., Orlando, B. J., Nandagiri, R. & Malkowski, M. G. Investigating substrate promiscuity in cyclooxygenase-2: the role of Arg-120 and residues lining the hydrophobic groove. J. Biol. Chem. 287, 24619-24630 (2012
36. Kainuma, M., Makishima, M., Hashimoto, Y. & Miyachi, H. Design, synthesis, and evaluation of non-steroidal farnesoid X receptor (FXR) antagonist. Bioorg. Med. Chem. 15, 2587-2600 (2007
37. Maloney, P. R. et al. Identification of a chemical tool for the orphan nuclear receptor FXR. J. Med. Chem. 43, 2971-2974 (2000
38. Yu, J. et al. Lithocholic acid decreases expression of bile salt export pump through farnesoid X receptor antagonist activity. J. Biol. Chem. 277, 31441-31447 (2002
39. Pellicciari, R. et al. 6?-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity. J. Med. Chem. 43, 3569-3572 (2002
40. Kliewer, S. A. et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc. Natl Acad. Sci. USA 94, 4318-4323 (1997
41. Forman, B. M. et al. 15-Deoxy-?12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83, 803-812 (1995
42. Fischer, A. S. et al. 5-Lipoxygenase inhibitors induce potent anti-proliferative and cytotoxic effects in human tumour cells independently of suppression of 5-lipoxygenase activity. Br. J. Pharmacol. 161, 936-949 (2010
43. Li, Y. et al. MK886 inhibits the proliferation of HL-60 leukemia cells by suppressing the expression of mPGES-1 and reducing prostaglandin E2 synthesis. Int. J. Hematol. 94, 472-478 (2011
44. Fujino, T. et al. Critical role of farnesoid X receptor for hepatocellular carcinoma cell proliferation. J. Biochem. 152, 577-586 (2012
45. Lea, M. A., Sura, M. & Desbordes, C. Inhibition of cell proliferation by potential peroxisome proliferator-activated receptor (PPAR) gamma agonists and antagonists. Anticancer Res. 24, 2765-2771 (2004
46. Tran, A. B. et al. Synthesis and activity of the archazolid western hemisphere. Org. Biomol. Chem. 9, 7671-7674 (2011
47. Berthold, M. R. et al. in Studies in Classification, Data Analysis, and Knowledge Organization (eds Preisach C. et al.) 319-326 (Springer, 2007
48. Kohonen, T. Self-Organizing Maps (Springer, 2001).